RA Capital Nexus Fund II, Director: Dice Therapeutics DICE Buy · Filed 23/03/30

Trade details

Type: Insider buy
Amount: $1,949,921.22
Shares · price: 66,369 sh · $29.38 a share
Held after: 6,874,208 sh
Stock: Dice Therapeutics DICE
Person: RA Capital Nexus Fund IIDirector
Trade date: 23/03/29
Filed: 23/03/30
Days to filing: 1 days

5 insiders bought this week

Insiders buying this week: 5 insiders
Holding change: +1.0%

Dice Therapeutics trades, last 26 weeks

What else happened in Dice Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/27~23/04/28

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06